Skip to main content

Table 1 Summary of the radiolabeling conditions

From: First preclinical evaluation of [225Ac]Ac-DOTA-JR11 and comparison with [177Lu]Lu-DOTA-JR11, alpha versus beta radionuclide therapy of NETs

 

Condition 1

Condition 2

Condition 3

MilliQ water

 

10 μL

10 μL

MilliQ water containing Kolliphor® HS 15 (2.0 mg/mL)

90.5 μL

  

TRIS buffer containing the peptide (0.1 M, pH 9)

 

75 μL

75 μL

Ascorbate buffer (1.0 M, pH 5.8)

 

50 μL

50 μL

l-melatonin (0.5 M)

  

10 μL

Gentisic/ascorbic acids (50 mM)

10 μL

  

Sodium acetate (2.5 M, pH 8)

1 μL

  

Ethanol

10 μL

  

Molar activity

50 kBq/nmol

100 kBq/nmol

100 kBq/nmol

DTPA (4 mM)

5 μL

5 μL

5 μL